Tests and estimates (transmission disequilibrium test) for allelic association of CCR5Δ32 with Asthma in high-risk families

Journal of the Pakistan Medical Association

Volumn 61, Issue 3, 2011, Pages 267-273

  Al Abdulhadi, Saleh Abdullah ^a   Al Rabia, M W ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

Adult; Association; Asthma; CCR5; Children; PDT; Polymorphism

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ALLELE; ALLERGIC ASTHMA; ARTICLE; ASTHMA; ATOPY; CHILD; CONTROLLED STUDY; FAMILY BASED ASSOCIATION TEST; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; PEDIGREE DISEQUILIBRIUM TEST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRICK TEST; SCHOOL CHILD; SKIN TEST; TRANSMISSION DISEQUILIBRIUM TEST; URTICARIA;

ADOLESCENT; ADULT; ALLELES; ALLERGENS; ASTHMA; CASE-CONTROL STUDIES; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; RECEPTORS, CCR3; RECEPTORS, CCR5; RESPIRATORY FUNCTION TESTS; SKIN TESTS; YOUNG ADULT;

EID: 79952240200     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Neote K, DiGregorio D, Mak, JY, Horuk, R, Shchall, TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-25.
2. Ponath PD, Qin S, Post TW. Molecular cloning and characterization of human eotaxin receptor expression selectively on eosinophils. Journal of Experimental Medicine 1996; 183: 2437-48.
3. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
4. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-5.
5. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine 1996; 2: 1240-1243.
6. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-62.
7. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-73.
8. Alam R. Chemokines in allergic inflammation. Journal of Allergy and Clinical Immunology 1997; 99: 273-7.
9. Hall IP, Wheatley A, Christie G, McDougall C, Hubbard R, Helms PJ. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354: 1264-5.
10. Mitchell TJ, Walley AJ, Pease JE, Venables PJ, Wiltshire S, Williams TJ, et al. Delta 32 deletion of CCR5 gene and association with asthma or atopy. Lancet 2000; 356: 1491-2.
11. McGinnis R, Child F, Clayton S, Davies S, Lenney W, Illig T, et al. Further support for the association of CCR5 allelic variants with asthma susceptibility. European Journal of Immunogenetics 2002; 29: 525-8.
12. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics 1996; 59: 983-9.
13. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. American Journal of Medical Genetics 2000; 64: 146-54.
14. Martin ER, Bass MP, Kaplan NL. Correcting for Potential Bias in the Pedigree Disequilibrium Test. American Journal of Medical Genetics 2001; 68: 1065-7.
15. Lucotte G. Distribution of the CCR5 gene 32-Basepair Deletion in West Europe. A hypothesis About the possible dispersion of the mutation by the Vikings in Historical times. Human Immunology 2001; 62: 933-6.
16. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M, et al. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. American Journal of Human Genetics 1998; 62: 1507-15.
17. Fryer AA, Spiteri MA, Bianco A, Hepple M, Jones PW, Stange RC, et al. The - 403 G-->A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes and Immunity 2000; 1: 509-14.
18. Srivastava P, Helms PJ, Stewart D, Main M, Russell G. Association of CCR5Delta32 with reduced risk of childhood but not adult asthma. Thorax 2003; 58: 222-6.
19. Al-Abdulhadi SA, Al-Rabia MW. Association and preferential transmission of the CCR2V64I polymorphism with absence of asthma in high-risk families. Saudi Medical J 2008; 29: 1711-8.
20. Nickel R, Beck LA, Stellato C, Schleimer RP. Chemokines and allergic disease. Journal of Allergy and Clinical Immunology 1999; 104: 723-42.
21. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 1996; 271: 17161-6.